MedTech News
.................... by Andrew Celentano

MIT spinout makes surgical stitching more like applying a sticky note
SanaHeal has developed a biologically compatible adhesive that sticks to wet tissues to simplify a variety of surgeries.

Haemonetics wins FDA approval of PerQseal Elite vascular closure system
Haemonetics (NYSE: HAE) has received FDA approval for its PerQseal Elite vascular closure system for large-bore arterial procedures, following the company’s $116.4 million acquisition of Vivasure Medical in January 2026.

Abbott’s Cologuard Plus screening test receives CE Mark
Abbott (NYSE: ABT) has received approval in Europe for its updated Cologuard Plus screening test for colorectal cancer, ahead of plans for a phased rollout across the continent.

Flavonoid found in citrus slows lung cancer cell growth in lab tests
Quercetin is found in citrus fruits, onions and buckwheat and is known for its anti-inflammatory properties. Now researchers at Universitätsklinikum Erlangen at Friedrich-Alexander Universität Erlangen-Nürnberg (FAU) have investigated how the plant compound could help treat lung cancer.

Novel blood test detects lung cancer traces long before scans
Despite advances in early-stage lung cancer treatment, a significant number of patients experience disease recurrence after surgery or initial therapy. A study has now demonstrated that a blood test (liquid biopsy) can reliably detect lingering lung cancer traces even in the earliest clinical stages, long before a tumor is large enough to show up on a scan.

Cell therapy using cardiac muscle cell aggregates improves heart function following a heart attack
In the event of a heart attack, the affected part of the heart muscle can no longer be supplied with oxygen and nutrients. As a result, the heart muscle cells (cardiomyocytes) die off. Scar tissue forms, and heart function is impaired. This often leads to chronic heart failure—also known in medical terms as cardiac insufficiency. It is one of the most common causes of death in the Western world.

AI is helping pathologists find harmful lesions the eye can’t see
As a pathologist, Dr. Christopher Owens has spent his career trying to improve his methods of catching precancerous colorectal polyps in patients. If he could catch cases earlier, fewer people would develop colorectal cancer, he said.

Harnessing the heart’s natural defense against heart attack damage
Researchers are investigating whether the body’s built-in response to low oxygen can be harnessed to reduce heart damage during heart attacks and surgery, using drugs that are already available.